Home » Authors » Nuala Moran

Nuala Moran

Articles

ARTICLES

Cyclacel Moves Oral CDK Inhibitor Into Human Trials

Feb. 21, 2001

Pharming Completes Study, Enters Deal With AM-Pharma

Feb. 21, 2001

Cyclacel Moves Oral CDK Inhibitor Into Human Trials

Feb. 21, 2001

Xenova, Cantab Merging Via All-Stock Deal Valued At £124

Feb. 21, 2001

Pharming Completes Study, Enters Deal With AM-Pharma

Feb. 21, 2001

HUPO Formed To Capitalize On Genome, Advance Proteomics

Feb. 20, 2001

HUPO Formed To Capitalize On Genome, Advance Proteomics

Feb. 20, 2001

KS Biomedix Moves Lead Drug Into Phase IIb, Eyes Pivotal Trial

Feb. 14, 2001

Antisoma Planning Financing To Stay Ahead, Keep Flexibility

Feb. 14, 2001

Oxford Glyco Plans Gaucher NDA On Cerezyme Comparison Study

Feb. 14, 2001

View All Articles by Nuala Moran

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...